Literature DB >> 26525384

Pyoderma Gangrenosum After Enzymatic Debridement.

Mark Duncan1, Scott Worswick2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26525384      PMCID: PMC4835390          DOI: 10.1007/s11606-015-3532-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.

Authors:  A M Binus; A A Qureshi; V W Li; L S Winterfield
Journal:  Br J Dermatol       Date:  2011-12       Impact factor: 9.302

Review 2.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

3.  Pyoderma gangrenosum and monoclonal gammopathy.

Authors:  F C Powell; A L Schroeter; W P Su; H O Perry
Journal:  Arch Dermatol       Date:  1983-06

4.  Pyoderma gangrenosum: a review of 86 patients.

Authors:  F C Powell; A L Schroeter; W P Su; H O Perry
Journal:  Q J Med       Date:  1985-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.